Work

Deep and Durable Responses with Weekly Ixazomib, Lenalidomide, and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma (NDMM): Long-Term Follow-up of Patients Not Undergoing Stem Cell Transplantation (SCT)

Year: 2017

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2017.07.151

Authors: Shaji Kumar, Jesus Berdeja, Ruben Niesvizky, Sagar Lonial, Jacob Laubach, Mehdi Hamadani, A. Keith Stewart, Parameswaran Hari, Vivek Roy, Robert Vescio, Jonathan Kaufman, Deborah Berg, Eileen Liao, Vincent Rajkumar, Paul Richardson

Institutions: Mayo Clinic, Sarah Cannon, NewYork–Presbyterian Hospital, Weill Cornell Medical Center, Winship Cancer Institute, Dana-Farber Cancer Institute, West Virginia University, Mayo Clinic in Arizona, Medical College of Wisconsin, Mayo Clinic in Florida, Cedars-Sinai Medical Center, Takeda Oncology (United States)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2752740163

FWCI: 0.363

Cites:

Cited by: 2

Related to: 10